Search results
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
St. Joseph News-Press· 48 minutes agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387,...
Closure of Gaza's only route out leaves boy, 10, with no treatment for cancer
Reuters via Yahoo News· 7 minutes agoSiraj Yassin, 10, is rolled into the overcrowded Gaza hospital ward in his wheelchair, his light...
Did the WRC’s shorter sprint-style format work?
Motorsport.com· 43 minutes agoThe shorter concept trialled in Sardinia may be complemented by the prospect of endurance rallies covering more than five days, in addition to ...
As Destiny 2's The Final Shape expansion brings a 10-year saga to a close, one lead promises Bungie...
Games Radar· 41 minutes agoVeteran Destiny 2 developers have addressed the "barriers" to entry with the MMO, and how Bungie has...
Up 218%, Is AST SpaceMobile a Buy Now?
The Motley Fool via AOL· 20 minutes agoAST SpaceMobile (NASDAQ: ASTS) has been a top-performing stock over the past month, but is the stock a buy? Travis Hoium digs into < ...
Fringe to premiere taster of Willy Wonka event musical
BBC via Yahoo News· 15 minutes agoSongwriters Alan Zachary and Michael Weiner said: "We love musicals with epic opening numbers. "And we thought - what could be more epic than John Stamos...
Emma Hayes won't let her USWNT coaching dream turn into a nightmare
LA Times via Yahoo Sports· 20 minutes agoDoing that, she said, starts with building a foundation of trust, which is why she met individually...
Returns On Capital At Vistra (NYSE:VST) Have Hit The Brakes
Simply Wall St. via Yahoo Finance· 19 minutes agoFirstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and...
With 74% institutional ownership, DoorDash, Inc. (NASDAQ:DASH) is a favorite amongst the big guns
Simply Wall St. via Yahoo Finance· 19 minutes agoWhile it makes sense to study institutional ownership data for a company, it also makes sense to...
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
Motley Fool via Yahoo Finance· 35 minutes agoMost Wall Street analysts covering the stock don't see any actual earnings growth happening until...